EA201400950A1 - Способы распространения комплемент-ингибирующих лекарственных средств среди пациентов, получающих ингибитор комплемента - Google Patents
Способы распространения комплемент-ингибирующих лекарственных средств среди пациентов, получающих ингибитор комплементаInfo
- Publication number
- EA201400950A1 EA201400950A1 EA201400950A EA201400950A EA201400950A1 EA 201400950 A1 EA201400950 A1 EA 201400950A1 EA 201400950 A EA201400950 A EA 201400950A EA 201400950 A EA201400950 A EA 201400950A EA 201400950 A1 EA201400950 A1 EA 201400950A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- complete
- patients
- methods
- distributing
- inhibitor
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2012/029499 WO2013137912A2 (fr) | 2012-03-16 | 2012-03-16 | Méthodes de distribution de médicaments inhibant le complément aux patients recevant un inhibiteur de complément |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201400950A1 true EA201400950A1 (ru) | 2014-12-30 |
Family
ID=49161929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201400950A EA201400950A1 (ru) | 2012-03-16 | 2012-03-16 | Способы распространения комплемент-ингибирующих лекарственных средств среди пациентов, получающих ингибитор комплемента |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2825989A4 (fr) |
CN (1) | CN104205155A (fr) |
EA (1) | EA201400950A1 (fr) |
HK (1) | HK1204693A1 (fr) |
IL (1) | IL234680A0 (fr) |
WO (1) | WO2013137912A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2930544A1 (fr) * | 2013-11-13 | 2015-05-21 | Shire Viropharma Incorporated | Utilisations d'inhibiteur de c1-esterase pour le traitement de la neuromyelite optique et des maladies du spectre de la neuromyelite optique, et compositions le comprenant |
CN105260974A (zh) * | 2015-09-10 | 2016-01-20 | 济南市儿童医院 | 一种生成具有告签功能的电子病历方法及系统 |
CN115177291B (zh) * | 2022-08-01 | 2023-11-10 | 首都医科大学附属北京朝阳医院 | 用于识别重症监护病房获得性肌无力的方法和装置 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6315720B1 (en) * | 2000-10-23 | 2001-11-13 | Celgene Corporation | Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug |
US20040117126A1 (en) * | 2002-11-25 | 2004-06-17 | Fetterman Jeffrey E. | Method of assessing and managing risks associated with a pharmaceutical product |
US20050169921A1 (en) * | 2004-02-03 | 2005-08-04 | Leonard Bell | Method of treating hemolytic disease |
US20060062734A1 (en) * | 2004-09-20 | 2006-03-23 | Melker Richard J | Methods and systems for preventing diversion of prescription drugs |
HUE030105T2 (en) * | 2006-03-15 | 2017-04-28 | Alexion Pharma Inc | Treatment of paroxysmal nocturnal hemoglobin uptake with complement inhibitor |
US8478605B2 (en) * | 2006-07-17 | 2013-07-02 | Walgreen Co. | Appropriateness of a medication therapy regimen |
WO2008021954A2 (fr) * | 2006-08-09 | 2008-02-21 | Biogen Idec Ma Inc. | Procédé de distribution d'un médicament |
PL2894165T3 (pl) * | 2008-11-10 | 2023-04-17 | Alexion Pharmaceuticals, Inc. | Sposoby i kompozycje do leczenia zaburzeń układu dopełniacza |
US8362210B2 (en) * | 2010-01-19 | 2013-01-29 | Xencor, Inc. | Antibody variants with enhanced complement activity |
-
2012
- 2012-03-16 WO PCT/US2012/029499 patent/WO2013137912A2/fr active Application Filing
- 2012-03-16 EP EP12870989.6A patent/EP2825989A4/fr not_active Ceased
- 2012-03-16 CN CN201280071445.8A patent/CN104205155A/zh active Pending
- 2012-03-16 EA EA201400950A patent/EA201400950A1/ru unknown
-
2014
- 2014-09-16 IL IL234680A patent/IL234680A0/en unknown
-
2015
- 2015-05-29 HK HK15105150.8A patent/HK1204693A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN104205155A (zh) | 2014-12-10 |
EP2825989A4 (fr) | 2016-01-06 |
HK1204693A1 (en) | 2015-11-27 |
WO2013137912A3 (fr) | 2014-05-01 |
EP2825989A2 (fr) | 2015-01-21 |
WO2013137912A2 (fr) | 2013-09-19 |
IL234680A0 (en) | 2014-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
BR112015009948A8 (pt) | Antagonistas de ativina-actrii, usos dos mesmos para tratamento de doenças ósseas e outros distúrbios e método para monitorar a eficácia do tratamento ou prevenção de uma doença óssea e outros distúrbios | |
MX2015012559A (es) | Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson. | |
BR112015003188A2 (pt) | Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
BR112015018168A2 (pt) | inibidores de rock suaves | |
EA201590655A1 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
AR096892A1 (es) | Una combinación farmacéutica para el tratamiento del melanoma | |
BR112012022552A8 (pt) | uso de fenoterol e de análogos de fenoterol no tratamento de gliobastomas e astrocitomas e composição farmacêutica compreendendo os referidos compostos | |
CL2014002935A1 (es) | Metodo para tratar un paciente humano con esclerosis multiple con laquinimod, en una dosis diaria de alrededor de 1,2mg; un aforma de dosificacion unitaria oral de 1,2 mg de laquinimod y un portador | |
NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
EA201590726A1 (ru) | Лахинимод для уменьшения таламического поражения при рассеянном склерозе | |
MX2017004772A (es) | Composiciones y métodos para la administración fisiológica utilizando cannabidiol. | |
EA201590797A1 (ru) | Препараты с модифицированным высвобождением опрозомиба | |
NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
EA201491427A1 (ru) | Замещенные фенилимидазопиразолы и их применение | |
NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
MA39447A1 (fr) | (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
EA201400950A1 (ru) | Способы распространения комплемент-ингибирующих лекарственных средств среди пациентов, получающих ингибитор комплемента | |
MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
BR102012028120B8 (pt) | Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento | |
EA201591603A1 (ru) | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах | |
EA201301275A1 (ru) | Соединения, фармацевтические композиции и способ профилактики и лечения спаечного процесса | |
BR112015007095A8 (pt) | derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados, composição farmacêutica compreendendoos e uso dos referidos derivados |